Navigation Links
PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
Date:2/7/2008

PEMBROKE, Bermuda, Feb. 7 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) announced that its Board of Directors has declared a dividend for the period December 1, 2007 - February 29, 2008 of $0.421875 per share on the Company's 6.75% Series C Cumulative Redeemable Preferred Shares, and $0.40625 per share on the Company's 6.5% Series D Cumulative Redeemable Preferred Shares. The dividends will be payable on March 3, 2008, to shareholders of record on February 22, 2008.

PartnerRe Ltd. is a leading global reinsurer, providing multi-line reinsurance to insurance companies. The Company, through its wholly owned subsidiaries, also offers alternative risk products that include weather and credit protection to financial, industrial and service companies. Risks reinsured include property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, life/annuity and health, and alternative risk products. For the year ended December 31, 2007, total revenues were $4.2 billion, total assets were $16.0 billion, and at December 31, 2007 total capital was $5.2 billion and total shareholders' equity was $4.3 billion.

PartnerRe on the Internet: http://www.partnerre.com

Contacts: PartnerRe Ltd. Sard Verbinnen & Co.

(441) 292-0888 (212) 687-8080

Investor Contact: Robin Sidders Drew Brown/Jane Simmons

Media Contact: Celia Powell


'/>"/>
SOURCE PartnerRe Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
4. Mylan Declares Quarterly Preferred Stock Dividend
5. NHP Increases Its Quarterly Common Dividend by $0.03 and Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
6. BD Board Declares Dividend
7. Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
8. Wyeth Declares Common and Preferred Stock Dividends
9. STERIS Corporation Declares Regular Quarterly Dividend
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... The Onder Law Firm’s at...those or families of those who may have experience...blems after taking XOLAIR. , ... Onder Law Firm are among attorneys offering free...uch as heart attack and stroke. The attorneys of ...
(Date:11/22/2009)...the skin,s surface, bacteria are abundant, diverse...esearch at the University of California, San Diego...eria living on the skin surface trigger a pathway ... , "These germs are actually good for us," said ...nd pediatrics, chief of UCSD,s Division of Dermato...
(Date:11/22/2009)...ing ahead can help keep eating under control, expe...ews) -- The holiday season means you,ll be faced w... While some people simply give in and eat too much...But there are ways to navigate between overindulge...anager of Nutrition Consult Services at Brigham an...
(Date:11/22/2009)... Man & Machine post You Tu...rsus the competition , La...eyboard users interested in learning what a really...tune into “Really Cool Keyboard vs Washable ... The film demonstrates how the premium, Really Co...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire/...atement after the Senate voted to begin full debat...Logo: http://www.newscom.com/cgi-bin/prnh/2008051...r historic step on the road to enacting health ins...urdle, senators will now have an opportunity to de...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2
...ctions during the first year of life are a marker ...arthritis later in life, according to new research...nual Congress of the European League Against Rheum...birthday had an increased likelihood of developing...
...sue of selling kidneys. , A regulated system of c...to the growing shortage of kidneys for transplanta... the University of Minnesota. , In many areas of...e annual death rate for suitable transplant candid...
...s, Inc., a,leader in orthopedic extremity implants...ves, William F. Warrender, Jr., John F. Walters an...eir extensive background and,experience will make ...He brings more than 25 years of sales, marketing a...
...in single nucleotide polymorphisms (SNPs) within t...n are shown to be associated with juvenile idiopat...wo independent cohorts presented today at EULAR 20...tic code), rs2104286, rs41295061 and rs11594656, w...
...HINGTON, June 13 A team of professionals,from Nat...rmany on Saturday,to work with the US Army,s Europ...eir current rehabilitation practices. They will al...n,services. The ERMC operates 15 ambulatory care c...
...to resolve remaining issues, TORONTO, June 13 /PR...PreMD Inc. (TSX: PMD; Amex: PME) today announced t...U.S. Food and Drug Administration (FDA) in an,effo...60 days PreMD and the FDA will work together to tr...
Other Medicine News:Health News:Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis 2Health News:What's wrong with selling kidneys? 2Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Specific mutations in the IL2RA gene associated with juvenile idiopathic arthritis 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5Health News:PreMD Reports Further Positive Meetings with the FDA 2
(Date:11/20/2009)...ETING, Pa., Nov. 20 In ... questions why currently available medications des...ignored, ECRI Institute, an independent nonprofit ...e on Finasteride for Prevention of Prostate Cance...9, New York Times article, " Drugs to Deter Some...
(Date:11/19/2009)...Ala., Nov. 19 BioCryst P...ced the pricing of a public offering of 5,000,000 ...ulting in gross proceeds of $48.75 million. All o...t to an effective shelf registration statement pre...mission. BioCryst has also granted the underwrite...
(Date:11/19/2009)...ov. 19 Riverain Medical announced ...ding Canadian medical imaging distributor Christie...d OnGuard Chest Xray CAD. The exclusive agreement ...roducts to the Canadian market through Christie Gr..., SoftView Enhanced Chest Imaging increases the c...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Scientists create NICE solution to pneumonia vaccine testing problems 10488 1Scientists create NICE solution to pneumonia vaccine testing problems 10488 2NSF awards Life in Transition grants to University of Oklahoma professors 10484 1NSF awards Life in Transition grants to University of Oklahoma professors 10484 2Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 1Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 2Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 3
...mpany,developing clinical stage treatments for can...y announced positive results from its Phase II,cli...e treatment of,advanced metastatic melanoma, at th...linical Oncology (ASCO) in Chicago, IL., Clinical...II trial was conducted at seven U.S.,clinical cent...
... HealthCore Presents Data on, Contributing Factors...t of Women with Breast Cancer and Reduc...oday,presented a study [Abstract No: 6593] compari... treatment guidelines for newly diagnosed breast,c...an Society of Clinical,Oncology (ASCO) in Chicago....
Other Medicine Technology:BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 4Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 2Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 3
Troutman-Barraquer Corneal Utility Forceps, Colibri Style - 0.5 mm
Catalano Corneal Scleral Forceps
Troutman-Barraquer Corneal Utility Forceps, Colibri Style
Colibri Forceps 0.12 mm
Medicine Products: